Cargando…
Pathway-Based Drug Response Prediction Using Similarity Identification in Gene Expression
Lapatinib and trastuzumab (Herceptin) are targeted therapies designed for patients with HER2+ breast tumors. Although these therapies improved survival rates of patients with this tumor type, not all the patients harboring HER2 amplification respond to these drugs. The NeoALTTO clinical trial was de...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509171/ https://www.ncbi.nlm.nih.gov/pubmed/33033492 http://dx.doi.org/10.3389/fgene.2020.01016 |